As of November 2024, Arch Biopartners has a market cap of $74.79M. This makes Arch Biopartners the world's 22854th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $64.23M | -5.41% |
2023 | $67.91M | -47.33% |
2022 | $128.93M | -18.55% |
2021 | $158.29M | 131.54% |
2020 | $68.36M | 53.61% |
2019 | $44.51M | -25.95% |
2018 | $60.11M | 184.78% |
2017 | $21.11M | 13.58% |
2016 | $18.58M | 26.56% |
2015 | $14.68M | 3.23% |
2014 | $14.22M | 72.22% |
2013 | $8.26M | 0.00% |
2012 | $8.26M | -64.00% |
2011 | $22.94M | -28.57% |
2010 | $32.12M | - |